WuXi NextCode Restructures, Rebrands as Genuity Science

NEW YORK – Multinational bioinformatics and sequencing firm WuXi NextCode has rebranded itself Genuity Science as it announced plans to restructure as a single entity while it sheds its Chinese operations.

Genuity Science will continue to offer contract genomics and artificial intelligence-driven data sourcing and data analytics services to the biopharmaceutical industry to support drug discovery and development. The company is headquartered in Boston and has offices in Reykjavik, Iceland, and Dublin, as well as CAP-accredited, CLIA-certified sequencing laboratories in Woburn, Massachusetts, and Dublin.

Read the full article here.